FDA Withdraws Approval For Ukoniq Cancer Drug Due To Possible Death Risk

(June 2, 2022, 12:18 PM EDT) -- SILVER SPRING, Md. — The Food and Drug Administration on June 1 said it has withdrawn its approval for the cancer drug Ukoniq after updated clinical trial results continued to show...
To view the full article, register now.